Investment Stage: Series D
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 27.06.2023 | Flywheel.i... | flywheel.io | $121.83M | United Sta... |
| 14.09.2021 | AgBiome | agbiome.com | $233M | United Sta... |
News 43
Show more
Mentions in press and media 22
| Date | Title | Description |
| 11.01.2026 | Flywheel Secures $27.5M, Propelling Medical Imaging AI and Clinical Trials | Flywheel, a key player in medical imaging data management, has closed $27.5 million in equity funding. This significant investment fuels product innovation. It accelerates growth, especially in clinical trials and AI model development. The ... |
| 09.01.2026 | Flywheel Closes $25M Equity Funding | Flywheel, a Minneapolis, MN-based provider of a medical imaging data management and analysis platform, raised $25M in equity funding. The round was led by Novalis Lifesciences and 8VC. The company intends to use the funds to further acceler... |
| 09.01.2026 | Flywheel Raises $27.5 Million And Expands Clinical Trial And Medical Device Offerings | Flywheel, a medical imaging data management and analysis platform, reported record momentum in 2025, launched new products aimed at clinical trial and medical device workflows, and disclosed the close of a $27.5 million equity financing rou... |
| 19.03.2025 | Telesis Bio: $21 Million Raised For Accelerating Adoption Of Gibson SOLA Technology | Telesis Bio, a provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, announced that it has entered into a convertible preferred stock purchase agreement to sell ... |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 27.06.2023 | Revolutionizing Medical AI Development: Flywheel Announces $54 Million in Series D Funding led by Novalis LifeSciences & NVentures | MINNEAPOLIS — (June 27, 2023) — Flywheel, the leading medical imaging data and AI platform, announces it has raised $54 million in Series D funding. This latest round of funding was co-led by Novalis LifeSciences LLC and NVentures, NVIDIA’s... |
| 23.08.2022 | mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA | - |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform 19-01-2022 Funds will allow for a rapid transition through pre-commercialization to market launch. London, UK and Woo... |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform | Funds will allow for a rapid transition through pre-commercialization to market launch. London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces it has sec... |
| 18.01.2022 | UK upstart raises $100M in bid to digitize and standardize cell and gene therapy manufacturing | Marijn Dekkers There’s a giant need for cell and gene therapy manufacturing options going forward, as companies move to invest massively into that space. Ori Biotech is the latest, as the UK-based biotech announced it ha... |
Show more